Time to Polish Those Resumes in Foster City | GenomeWeb

Yesterday's news that Invitrogen is buying Applied Biosystems for $6.7 billion stirred tremendous interest from the community. Our sister website GenomeWeb Daily News reports that "the deal would be the largest in the life sciences tools market since Thermo Electron bought Fisher Scientific for $10.6 billion in 2006." Invitrogen CEO Greg Lucier will head up the whole company, and current Applera CEO Tony White will be a consultant for five years once the deal is approved.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.